The market for contrast-enhanced digital mammography is changing significantly as a result of the release of mammography equipment software. The development of mammography software will result in slight growth for the healthcare industry. Mammography software offers the ability to boost clinical assurance and boost mammography systems’ effectiveness. Companies that provide contrast-enhanced digital mammography are increasing their R&D expenditures to create tools that utilize image processing driven by aluminium to automatically identify breast density. Contrast-enhanced digital mammography is a highly well-liked and commonly employed method because of the rising breast cancer incidence. Obesity, unhealthy alcohol use, age, gender, family history, radiation exposure, smoking, hormone therapy, and tobacco use are all risk factors for breast cancer. pictures of breast cancer created using dual energy subtraction and temporal subtraction procedures in contrast-enhanced digital mammography (CEDM).
The Global Contrast-Enhanced Digital Mammography (CEDM) Market was valued at US$ 320.3 Million in 2022 and is anticipated to reach US$ 748.8 Million by the end of 2030 with a CAGR of 11.2% from 2023 to 2030. (forecast period).
An iodinated contrast agent is injected during CEDM. By monitoring the uptake of iodine in breast tissue, CEDM can demonstrate the angiogenesis of breast cancer. Using this method, aberrant focal areas with higher micro vessel density are found. Contrast Enhanced Digital Mammography is a highly well-liked and commonly employed method as a result of the rising breast cancer incidence. Obesity, unhealthy alcohol use, age, gender, family history, radiation exposure, smoking, hormone therapy, and tobacco use are all risk factors for breast cancer.
Increasing Prevalence of Breast Cancer to Boost Global Contrast-Enhanced Digital Mammography (CEDM) Market
The market for contrast-enhanced digital mammography is expanding as a result of the rising incidence of breast cancer. One of the most often diagnosed tumours in women is breast cancer, and early diagnosis is essential for successful treatment and better patient outcomes. A contrast agent is used in contrast-enhanced digital mammography, often referred to as contrast-enhanced spectral mammography, to assist emphasize areas of concern in the breast tissue. Especially for women with dense breast tissue or those who are at high risk for the disease, this more recent technique has shown promise in enhancing the accuracy of breast cancer detection.
The market for contrast-enhanced digital mammography is anticipated to expand as more healthcare professionals use this technology for breast cancer detection and diagnosis. Factors like technological developments, greater knowledge about the benefits of early diagnosis, and increasing investments in healthcare infrastructure are also expected to help with market expansion. Additionally, the market for contrast-enhanced digital mammography is anticipated to rise in the next years due to the rising demand for minimally invasive procedures and the growing geriatric population.
North America to Spearhead the Global Contrast-Enhanced Digital Mammography (CEDM) Market
- Increasing Prevalence of Breast Cancer: Breast cancer is a serious health concern in North America, and the disease’s increasing frequency has raised the demand for cutting-edge diagnostic equipment like contrast-enhanced digital mammography.
- Advancements in Breast Imaging Technology: The development of sophisticated methods like contrast-enhanced digital mammography has been made possible by substantial developments in breast imaging technology over the past several years. The accuracy and dependability of breast cancer detection have significantly improved because of these new technologies.
- Increasing Awareness about Breast Cancer Screening: Rising awareness of the value of breast cancer screening among women in North America has resulted in a rise in demand for cutting-edge diagnostic technologies like contrast-enhanced digital mammography.
- Government Funding and Initiatives: The governments of North America have launched several programmes to support breast cancer research and screening. Due to this, funding for the creation of cutting-edge breast imaging technology, such as contrast-enhanced digital mammography, has grown.
- Accessibility of Qualified Healthcare Personnel: The expansion of the market in North America has also been aided by the accessibility of qualified healthcare personnel who can use modern breast imaging technologies like contrast-enhanced digital mammography.
Due to these and other factors, the contrast-enhanced digital mammography market in North America is anticipated to expand during the coming years.
Companies operating in the contrast-enhanced digital mammography market have adopted several growth strategies to expand their market share and increase their revenue. Some of the major players competing in the market include GE Healthcare, Siemens Healthineers (Siemens AG), Allengers Medical Systems Limited, Planmed Oy, Hologic, Inc., Carestream Health, Anke High-Tech, Angell Technology, BMI Biomedical International, Italy and others.
Collaborations and partnerships can truly bring about substantial advantages for businesses by leveraging each other’s expertise and strengths to create new technologies, services, or products. For instance, consider the fruitful collaboration between a software supplier and a medical device manufacturer. Their combined efforts can lead to the creation of innovative systems, like a Computer-Aided Detection and Diagnosis (CEDM) system, which seamlessly integrates diagnostic capabilities with imaging technology. A prime example of this approach can be seen in the partnership between GE Healthcare and ScreenPoint Medical. They’ve integrated AI technology with mammography devices to enhance breast cancer detection through sophisticated image analysis and accurate lesion identification.
The strategy of developing and launching new products also empowers businesses to offer improved solutions to healthcare providers. Take, for instance, the introduction of Fujifilm Medical Systems USA, Inc.’s ASPIRE Cristalle with Tomosynthesis Option and Contrast-Enhanced Mammography package. This showcases the potential of combining different technologies to significantly enhance accuracy and sensitivity in identifying breast cancer.
Expanding into new markets or strengthening their position in existing ones can be effectively achieved through joint ventures, partnerships, or acquisitions. Hologic, Inc.’s partnership with China Resources Wandong Medical Equipment Co. Ltd. serves as a great example of the market-expanding potential. This collaboration enables advanced breast cancer screening technologies to enter the rapidly growing Chinese market.
Mergers and acquisitions offer companies pathways to access untapped markets, innovative products, and emerging technologies. The acquisition of DermEbx by iCAD, Inc. is a case in point, illustrating how companies can diversify their product portfolio by venturing into new sectors.
Collectively, these strategic approaches empower businesses not only to enhance their presence in the market but also to foster innovation, develop cutting-edge products, and ultimately thrive in the dynamic CEDM market.